Viemed Healthcare (NASDAQ:VMD) Stock Breaks Below 200-Day Moving Average - Time to Sell?

Key Points

• Viemed Healthcare shares fell below their 200-day moving average, trading as low as $9.39 and most recently at $9.44, down 2.4%.
• Analyst sentiment has softened, with recent downgrades leaving the stock with a consensus “Hold” rating; the consensus price target remains $14.00.
• The company missed quarterly EPS expectations, reporting $0.07 versus the $0.12 consensus estimate, although revenue of $78.1 million slightly exceeded forecasts. Institutional investors own 74.24% of the shares.

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) shares crossed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $9.55 and traded as low as $9.39. Viemed Healthcare shares last traded at $9.44, with a volume of 226,688 shares traded.

Wall Street Analysts Forecast Growth

VMD has been the topic of several analyst reports. Weiss Ratings lowered shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, August 17th. Wall Street Zen downgraded Viemed Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 15th. Freedom Capital lowered shares of Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 5th. Finally, Barrington Research assumed coverage on Viemed Healthcare in a research report on Monday, August 24th. They issued an "outperform" rating and a $14.00 price target on the stock. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $14.00.

Viemed Healthcare Trading Down 2.4%

The company has a current ratio of 1.13, a quick ratio of 1.02 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $359.55 million, a P/E ratio of 26.22, a P/E/G ratio of 2.42 and a beta of 1.04. The firm has a 50-day moving average of $9.24 and a two-hundred day moving average of $9.55.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.05). The business had revenue of $78.10 million for the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. On average, analysts anticipate that Viemed Healthcare, Inc. will post 0.41 EPS for the current year.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in VMD. BlackRock Inc. bought a new position in Viemed Healthcare in the 2nd quarter valued at approximately $54,587,000. Nantahala Capital Management LLC acquired a new stake in Viemed Healthcare in the second quarter valued at approximately $7,209,873. Arrowstreet Capital Limited Partnership boosted its position in Viemed Healthcare by 101.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company's stock valued at $6,550,000 after buying an additional 358,863 shares in the last quarter. Punch & Associates Investment Management Inc. acquired a new stake in Viemed Healthcare in the second quarter valued at approximately $6,082,000. Finally, Raffles Associates LP bought a new stake in shares of Viemed Healthcare during the second quarter worth $4,602,000. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc NASDAQ: VMD is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company's offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.